Hongchang International Co., Ltd
HCIL- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001086303
In the last 90 days, Hongchang International Co., Ltd insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.80K in total
- 1
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HCIL, Q2 2026
No superinvestor reported holding HCIL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Hongchang International Co., Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 (view filing)6:01 AM ET | Jun 23-25 | 6 daysLate | Lin ZhenzhuDirector, 10% Owner | SSale | −16.4K | $0.1097 | −$1.80K | 0.0%62.2M after | 3 lots |
| Oct 3, 2023 (view filing) | Sep 28 | 5 daysLate | Ang Ban SiongDirector, 10% Owner | SSale | −28.3M | $28,328.19 | −$802.5B | −33.6%56.0M after | Price outlier |
| May 31, 2023 (view filing) | May 17 | 14 daysLate | Tan Hung SengDirector | PPurchase | +20.0M | $20,000.00 | +$400.0B | +40.0%70.0M after | Price outlier |
| May 25, 2023 (view filing) | May 17 | 8 daysLate | Ang Ban SiongCEO and President | SSale | −68.6M | $68,645.43 | −$4.71T | −7.5%843.4M after | Price outlier |
Top 10 13F holders, Q2 2026
The largest institutional positions in Hongchang International Co., Ltd at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding HCIL in 13F filings for Q2 2026.